REQUEST A DEMO
Total
USD $0.00
View basket Checkout now
Search more companies

Kronos Laboratorios C Ltda (Ecuador)

Main Activities: Pharmaceutical and Medicine Manufacturing
Full name: Kronos Laboratorios C Ltda Profile Updated: April 13, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English & Spanish Download a sample report

kronos laboratorios c. ltda is a pharmaceutical company specializing in the production of drugs and active ingredients for various infections and diseases, including malaria, schizophrenia, and bacterial infections. Their products include antipaludic drugs, neuroleptic drugs, and antibacterial agents. The company has developed or utilized technologies for their production processes.

Headquarters
Av. Primera
Guayaquil; Guayas;

Contact Details: Purchase the Kronos Laboratorios C Ltda report to view the information.

Website: http://www.kronoslaboratorios.com

Basic Information
Total Employees:
Purchase the Kronos Laboratorios C Ltda report to view the information.
Outstanding Shares:
Purchase the Kronos Laboratorios C Ltda report to view the information.
Registered Capital:
Purchase the Kronos Laboratorios C Ltda report to view the information.
Incorporation Date:
June 05, 1978
Key Executives
Purchase this report to view the information.
President
Purchase this report to view the information.
Vice President
Purchase this report to view the information.
Deputy General Manager
Purchase this report to view the information.
Manager
Ownership Details
Purchase this report to view the information.
28%
Purchase this report to view the information.
28%
Purchase this report to view the information.
15%
Purchase this report to view the information.
14%
Purchase this report to view the information.
2%
Company Performance
Financial values in the chart are available after Kronos Laboratorios C Ltda report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency USD. Absolute financial data is included in the purchased report.
Net sales revenue
-0.64%▼
Total operating revenue
-1.27%▼
Operating profit (EBIT)
5.18%▲
EBITDA
1.05%▲
Net Profit (Loss) for the Period
44.12%▲
Total assets
-1.67%▼
Total equity
13.69%▲
Operating Profit Margin (ROS)
0.18%▲
Net Profit Margin
0.34%▲
Return on Equity (ROE)
0.49%▲
Debt to Equity Ratio
1.04%▲
Quick Ratio
0.59%▲
Cash Ratio
0.06%▲

To view more information, Request a demonstration of the EMIS service

USD 29.95
Buy this company report
Need ongoing access to company, industry or country information?
Request a demo